Public Companies
Cory Booker Sends MindMed (MNMD) Stock Up 10%
Source: Daniel Patrick Martin / Shutterstock.com
Mind Medicine (NASDAQ:MNMD) stock is heating up on Tuesday thanks to Tweets from Sen. Cory Booker (D-NJ).
In…
Mind Medicine (NASDAQ:MNMD) stock is heating up on Tuesday thanks to Tweets from Sen. Cory Booker (D-NJ).
In a video Tweet, the Senator discussed the regulations surrounding psychedelics. He notes that this keeps them from seeing therapeutic use, despite recent research that suggests there’s such a case for them.
During his Tweets, Booker references his and Sen. Rand Paul’s (R-KY)”Right to Try” bill. This is legislation that would allow incredibly ill patients to try certain restricted drugs, such as psilocybin and marijuana.
Here’s a portion of what Booker says in the video, as transcribed by Marijuana Moment.
“We see that some drugs, like certain psychedelics, can help vulnerable people deal with their addiction, their trauma, their anxiety, their depression and more. Let’s make these drugs available for research, study and—ultimately, hopefully—for constructive application.”
Why MNMD Stock is Rising
All of those discussions are incredibly important to MindMed. The company’s main focus is on using psychedelics as a form of treatment for certain patients. The idea of a bill easing access to these types of drugs has investors excited today.
With that excitement comes heavy trading of MNMD stock. As of this writing, more than 2.6 million shares of the stock have been traded. To put that in perspective, the company’s daily average trading volume is closer to 1.3 million shares.
MNMD stock is up 9.9% as of Tuesday morning.
There’s more of the latest stock market news worth diving into below!
We’ve got all of that news ready for investors without daily coverage of the market. Among that is why shares of Mullen Automotive (NASDAQ:MULN), MBLY, and BYD (OTCMKTS:BYDDY) stock are doing. You can get up to speed on all of this news at the following links!
More Tuesday Stock Market News
- Mullen Is Getting Ready to Resell 900 Million Shares of MULN Stock
- MBLY Stock IPO: When Does Mobileye Go Public? What Is the Mobileye IPO Price Range?
- BYD Company (BYDDY) Stock Rises as Quarterly Profits Quadruple
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
More From InvestorPlace
- Buy This $5 Stock BEFORE This Apple Project Goes Live
- The Best $1 Investment You Can Make Today
- Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
The post Cory Booker Sends MindMed (MNMD) Stock Up 10% appeared first on InvestorPlace.
psychedelics psilocybin mind medicine mindmed-
LSD1 week ago
The First Wave of Blotter Acid Inspired Trippy Psychedelic Art
-
Psilocybin1 week ago
Psychedelic Underground Celebrated in San Francisco on Bicycle Day Weekend
-
Psychedelics6 days ago
Compass Pathways and Journey Clinical Establish Research Collaboration Agreement To Inform the Training of Healthcare Providers and Delivery Model for COMP360 Psilocybin Treatment, If Approved for Treatment-Resistant Depression
-
Psychedelics6 days ago
Cybin to Participate at the 27th Annual Milken Institute Global Conference
-
Psychedelics4 days ago
Behold! A New Mushroom Emoji Has Arrived!
-
Psychedelics4 days ago
Freedom Biosciences Announces FDA Approval of IND Application for FREE001 in Patients with Treatment-Resistant Depression
-
Psychedelics4 days ago
Are ‘Ketamine Bros’ Ruining It for Everyone Else?
-
Ketamine4 days ago
DEA poised to move cannabis to Schedule III